2025 annual financial data
Maze Therapeutics 2025 Operating margin
Maze Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -142,899,000 USD and net income was -131,120,000 USD.
Operating cash flow was -111,940,000 USD.
Get free Maze Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -142,899,000 USD
- Net income
- -131,120,000 USD
- Operating cash flow
- -111,940,000 USD